Latest Mitral valve Stories
NASDAQ: NVCNTSX: NVC VANCOUVER, Oct. 9, 2014 /PRNewswire/ - Neovasc Inc.
Funds to Be Used to Extend Commercial Efforts, Capitalize on Promising Patient Data KIRKLAND, Wash., Oct.
JENA, Germany, September 29, 2014 /PRNewswire/ -- Occlutech, a leading innovator of products to treat structural heart disease today announced that it has obtained a European
Third Multi-Center Study Shows Compelling Results Consistent with Previous Trials; Data Presented at TCT KIRKLAND, Wash., Sept. 17, 2014 /PRNewswire/ -- Cardiac Dimensions(®), Inc.
Tiara(TM) Transcatheter Mitral Valve program featured in multiple scientific presentations NASDAQ: NVCNTSX: NVC WASHINGTON, DC, Sept.
Harpoon Medical Has Received More than $3M of its Series A Financing to Fund the Initial Clinical Evaluation of the Company's Minimally Invasive Mitral Valve Repair Device STEVENSVILLE,
STASIS Clinical Study Begins in Europe NEWTOWN, Pa., Sept. 9, 2014 /PRNewswire/ -- Micro Interventional Devices, Inc.
- Medicare will Provide National Coverage for People with Severe Degenerative Mitral Regurgitation Deemed Too Sick for Surgery ABBOTT PARK, Ill., Aug.
Valve Clinic Team is first locally to use device for Mitral Valve Regurgitation CLEARWATER, Fla., Aug.
- A political dynamiter.